1.
Mayo Clin Proc
; 81(4): 545-8, 2006 Apr.
Artículo
en Inglés
| MEDLINE
| ID: mdl-16610576
RESUMEN
The Food and Drug Administration has banned the sale of ephedrine-based weight-loss products because of their association with many cardiovascular adverse effects. Bitter orange is now being used as a stimulant in "ephedra-free" weight-loss supplements but was recently implicated in adverse cardiovascular sequelae. To our knowledge, this report describes the first case of variant angina associated with bitter orange in a dietary supplement.
Asunto(s)
Angina Pectoris Variable/inducido químicamente , Suplementos Dietéticos/envenenamiento , Sinefrina/envenenamiento , Vasoconstrictores/envenenamiento , Angina Pectoris Variable/diagnóstico , Diagnóstico Diferencial , Electrocardiografía , Humanos , Masculino , Persona de Mediana Edad
2.
Circulation
; 120(13): e96-7, 2009 Sep 29.
Artículo
en Inglés
| MEDLINE
| ID: mdl-19786638